Skip to content
Search

Latest Stories

Pharmacy law legend Joy Wingfield dies of Covid-19

Professor Joy Wingfield, a pharmacy law authority and founder of the Pharmacy Law & Ethics Association, has died from Covid-19.

She was chair of the PLEA until 2015 and made a major contribution, breaking new ground in the way she brought to the fore the subject of ethics in pharmacy teaching and practice.


Professor Wingfield began as an inspector of the Royal Pharmaceutical Society of Great Britain when the Society was a regulator of the pharmacy profession.

"A titan in the field of pharmacy law and ethics," Joy edited Dale & Appelbe’s Pharmacy and Medicines Law for nearly a quarter of a century.

She wrote widely on pharmacy ethics, co-authoring Pharmacy Ethics and Decision Making (2007) and writing Practical Exercises in Pharmacy Law and Ethics (1997, 2002).

Following her retirement, Joy became honorary professor of Pharmacy Law and Ethics at the University of Nottingham. Until 2017, she maintained a pharmacy consultancy - Wingfield Works - enabling pharmacists and organisations to continue to benefit from her expertise and wisdom.

When approached by Pharmacy Business, her successor at PLEA David Reissner fondly remembered Professor Wingfield and said: "I first met Joy in the early 1980s when I was representing a pharmacist and she was an inspector of the Royal Pharmaceutical Society.

"I am honoured that when she retired, she asked me to take over from her as co-editor of Pharmacy Law & Ethics and also to follow her as chair of the Pharmacy Law & Ethics Association."

Here are of the number of tributes and condolences being shared across Twitter timelines over her untimely demise:

https://twitter.com/Pharmacistdaz/status/1362103317996982277?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1362103317996982277%7Ctwgr%5E%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fwww.chemistanddruggist.co.uk%2Fnews%2Fpharmacy-pays-tribute-plea-founder-joy-wingfield-who-died-covid

The exact circumstances of her passing away are yet to be known.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less